« Back
Carboxyhemoglobin Levels in Smokers and Non-Smokers Undergoing Various Cardiac Surgical Procedures Using Cardiopulmonary Bypass
Carboxyhemoglobin Levels in Smokers and Non-Smokers Undergoing Various Cardiac Surgical Procedures Using Cardiopulmonary Bypass
Submitted on 09 Jul 2018

Jose Puentes, Pharm D, Amjad Najim, MD, Nadine Odo, CCRC, ELS, and Shvetank Agarwal, MD, FASE
Augusta University
This poster was presented at Georgia Society of Anesthesiologist Summer Meeting Student Posters
Poster Views: 203
View poster »
Poster Abstract
Low levels of endogenous and exogenous carbon monoxide has been shown to be cytoprotective in various pathophysiological conditions such as organ transplantation, ischemia/reperfusion, inflammation, sepsis, and shock states.1,3 The inducible isoform of microsomal heme oxygenase-1 (HO-1) found in reticuloendothelial cells is the main producer of endogenous carbon monoxide. Known stressors and inducers of HO-1 gene expression include surgery, anesthesia and cardiopulmonary bypass (CPB).2
Cigarette smokers can have carboxy-hemoglobin (COHb) levels that are 2 to 10 times higher than that of non-smokers. It has been suggested that smoking may have a protective effect and could lead to favorable outcomes compared to non-smokers. The aim of this study was to examine COHb levels from pre-induction to arrival in the intensive care unit (ICU) as well as the clinical impact of COHb changes among smokers as compared to non-smokers undergoing CPB.

In this retrospective cohort study, adult patients that were admitted to Augusta University Medical Center for coronary artery bypass graft (CABG) alone, CABG in combination with valve repair or replacement, or valve surgery alone, whether elective or emergent, from April 1, 2012, to January 1, 2016, were included in the study. Patients who died before an arterial blood gas sample could be obtained in the ICU were excluded.

total of 193 patients (42 smokers and 151 non-smokers) were identified. Two patients were excluded because of insufficient data. Other than age (smokers were significantly younger than non-smokers; p=0.004) demographics such as sex and race as well as mean intraoperative variables such as CPB and aortic cross clamp times were comparable between the two groups (Table 1).
Smokers had significantly higher COHb levels at baseline (p<0.001), just prior to CPB (p<0.001), and immediately after weaning off CPB (p<0.001). COHb levels on arrival to the ICU were similar in the two groups. Smokers had a more significant drop in COHb from baseline to the first ICU value compared to non-smokers (p<0.001). There was no significant difference in the ICU or hospital length of stay between the two groups.
In a subgroup analysis comparing patients who underwent a CABG to those who underwent valve procedures showed a significantly higher COHb levels in non-smoking valve patients on arrival to ICU as well as change in COHb levels from preinduction to ICU as compared to CABG only patients, suggesting that a higher degree of systemic stress causes a higher production of endogenous COHb.

The more pronounced reduction in COHb levels following CPB in smokers as compared to non-smokers suggests that smokers have decreased endogenous production of CO in response to systemic stress. It is reasonable to conclude that exogenous CO in smokers has a “preconditioning effect” by reducing the overall systemic stress response

Baur I, Pannen B: Bench to bedside review: carbon monoxide–from mitochondrial poisoning to therapeutic use. Crit Care. 2009;13(4):220.
Ferrandiz ML, Devesa I: Inducers of heme oxygenase-1. Curr Pharm Des. 2008;14:473-486.
Pulido JN, Neal JR, Mantilla CB, et al: Inhaled carbon monoxide attenuates myocardial inflame-matory cytokine expression in a rat model of cardiopulmonary bypass. J Extra Corpor Technol. 2011;43:137-143.
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

A Novel Enzymatic Assay for Determination of Phosphatidylinositol in Biological Samples
Paul Templeton, Kyle C. Schmitt, Grigoriy Tchaga,and Gordon Yan

A Novel Method For Discovery of Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis Using Extensive Depletion and TMTcalibratorTM Tissue-Enhanced Plasma Proteomics
I. Pike1, M. Bremang1, P.J. Wolters 2, R. Gaster3, S. Turner3, M. Decaris3

Nikita Gandotra

Things just keep changing: Family caregivers' perceptions of the impact of Huntington's disease on caregiver burden
Jess Kaplonyi, Dr Christopher Lind, Catherine Christian, Irene Scott

The EurOPDX EDIReX project: towards a European Research Infrastructure on patient-derived cancer models
E. Vinolo 1, J.P. Morris 1, D.G. Alférez 2, J. Arribas 3,4,5, C. Bernadó 3,4,5, A. Bertotti 6, A. Bruna 7, A.T. Byrne 8, C. Caldas 7, R.B. Clarke 2, N. Conte 9, R. Corsi 10, S. Corso 6, M. Crespo 3, A. Dahmani 11, V. Dangles-Marie 11, D. Decaudin 11, Z. Dudová 12, A. Fiori 6, S. Giordano 6, M. Hauptsmann 13, M. Hidalgo 14, C. Isella 6, S. de Jong 15, J. Jonkers 13, A. Křenek 12, O. Krijgsman 13, D. Kouřil 12, J.C. Lacal 14, L. Lanfrancone 16, E. Leucci 17, G.M. Mælandsmo 18, E. Marangoni 11, J. Mason 9, M.Th. Mayrhofer 19, A. Mazzocca 6, T.S. Meehan 9, E. Montaudon 11, F. Nem